We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GCBC:NASDAQGreene County Bancorp, Inc. Analysis

Data as of 2026-05-23 - not real-time

$25.07

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Greene County Bancorp (GCBC) is trading at $25.07, comfortably above its 20‑day ($24.31), 50‑day ($23.44) and 200‑day ($23.09) simple moving averages, indicating a bullish price trend. The stock’s RSI of 62.8 and a bullish MACD histogram (+0.067) reinforce momentum, though the RSI suggests the shares are approaching overbought territory. Valuation metrics are compelling: a trailing P/E of 10.95 is well below the industry average of 16.75, and the DCF‑derived fair value of $53.36 points to substantial upside potential. The dividend yield of 1.6% with a modest 17% payout ratio appears sustainable given strong operating cash flow ($37.3 M) and a net cash position (cash $144.5 M vs debt $110.2 M).
Recent earnings released for Q3 showed net income of $10.5 M, a 36% YoY increase, and the board announced a stock repurchase program, underscoring confidence in the balance sheet. Revenue grew 23% year‑over‑year to $86.4 M, while operating and profit margins sit at 53% and 45% respectively, supporting a healthy ROE of 15.7%. These fundamentals, combined with a low beta (~0.85) and a sector‑wide “Extreme Greed” sentiment, suggest GCBC is positioned for continued outperformance.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Price approaching resistance at $25.48
  • RSI nearing overbought levels
  • Decreasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong earnings beat and 36% YoY net income growth
  • Undervalued valuation (P/E vs industry, DCF upside)
  • Sustainable dividend and cash‑rich balance sheet

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Consistent revenue growth and high profit margins
  • Low beta indicating defensive profile
  • Ongoing share repurchase program and dividend stability

Key Metrics & Analysis

Financial Health

Revenue Growth23.40%
Profit Margin45.14%
P/E Ratio10.9
ROE15.71%
ROA1.26%
P/B Ratio1.6
Op. Cash Flow$37.3M
Industry P/E16.8

Technical Analysis

TrendBullish
RSI62.8
Support$23.28
Resistance$25.48
MA 20$24.31
MA 50$23.44
MA 200$23.09
MACDBullish
VolumeDecreasing
Fear & Greed Index91.61

Valuation

Fair Value$53.36
GradeUndervalued
TypeBlend
Dividend Yield1.60%

Risk Assessment

Beta0.85
Volatility24.52%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.